A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia
about
Use of licensed vaccines for active immunization of the immunocompromised hostThe lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infectionPathogenesis and pathophysiology of bacterial meningitis.Role of complement in host defense against pneumococcal otitis mediaKinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells.Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivoInteraction of pneumococcal histidine triad proteins with human complement.Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice.Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteriaBlood clearance and tissue distribution of 99Tc-labelled pneumococci following splenectomy in rabbits.Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsuleMonoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx.Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors.Antiphagocytic effect of the capsule of Staphylococcus simulans.Species-specific interaction of Streptococcus pneumoniae with human complement factor H.Alternative complement pathway activation increases mortality in a model of burn injury in miceInteraction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitroAntibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.Streptococcus pneumoniae serotype 11D has a bispecific glycosyltransferase and expresses two different capsular polysaccharide repeating units.Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniaeClassical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody moleculesThe fundamental link between pneumococcal carriage and disease.Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.Antifungal activity of a human antiglucuronoxylomannan antibody.Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.
P2860
Q24533456-3E16E009-032A-4498-B72C-31125659878EQ28727502-40FCCDFF-66F8-4CEE-902B-15748A42C974Q30450181-FB5B3B86-CDF1-4D36-9CC1-90552C73FCB9Q33399371-2C2F5686-4414-4628-9432-0123F6D0B603Q33557154-62AF1118-BADE-404D-8417-7BEF5CF426B5Q33602800-A9183130-032B-431B-BB9F-55DD48C11A8FQ33703237-D438B1A6-1AFD-4706-99EA-1CA0C65B0603Q33825652-403A445B-A38D-443E-AEC0-9D145887932AQ33826119-0E3B2090-A2F8-4E22-9262-090A4584D923Q34001504-87071AC9-9347-4E75-AADF-1E4AE68729B5Q34130657-56C4D021-C955-42EF-B97A-639A0186DE2BQ34309639-564F60C3-841C-4FFE-9F44-767A75616595Q34521565-EA191BCD-E1DD-4E1E-B69C-6948B8271AB1Q34558270-B9A4DA81-81B9-420D-8188-9FA84D448090Q34581644-67D33BB8-435C-41F2-89D8-1E425329E67CQ35095675-6957B538-5234-4560-B5B6-383AFDB72D4AQ35533996-EACF341A-BD9C-4077-983D-450CF4DBEA19Q35587941-8AA1E09C-10E1-48BC-B5F9-5156EAE3FA01Q35778597-69EC1AA6-119C-43F0-BE82-344F90786CBDQ35779863-03B7FE89-D91D-489D-A835-499E201FF38FQ36029410-87924654-CBBA-4060-A222-EF2A5D650E72Q36089774-3DF1B8E0-BA8F-4473-BF75-FDB07666419AQ36333075-782D1989-D241-4D76-A955-FC3065BF52E3Q36342702-70B182F2-FC04-41A1-B197-1B01B1B899D6Q36349356-CBB33B37-4D9B-46D3-8AE5-01BF1782D0D0Q36487485-4543B709-22DF-4629-AAD7-E0CC12FAC0B0Q36951376-D1268611-9919-4E11-B160-B1D633F12740Q36972878-872F30BA-DABB-492F-90D9-C5B51F0F70CDQ36981129-8A7B0928-6D9C-41B3-8155-7ABB87E47108Q36984721-4DEA69F4-E9E8-4F92-8340-9DF3388FE2F1Q36988329-A4F17926-08E6-427E-B5DA-FC324030F820Q36989940-3571D7F7-D855-476D-8EDC-DE2083A3663BQ37033022-7E9FE3C4-B4C2-44D2-BC91-9F318630F3ABQ37048457-6043DE7F-8D05-4F5C-9326-1A63151CA705Q37053139-98369C3E-D2BB-4C5E-83F6-612434882EE1Q37102226-727F0A21-9AED-43A9-9582-D8EFB1685819Q38036689-60F45698-D450-4F05-B6BC-19E112DF241FQ39511742-2092FE9F-3519-4108-894B-6D415A0B6ED5Q39630861-F0EB2608-C7B6-4860-985D-8F6A5D8FFD40Q40183887-39D2FED0-25D8-4614-9FB6-00E99EFE1C0D
P2860
A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1982
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A quantitative analysis of the ...... mental pneumococcal bacteremia
@en
A quantitative analysis of the ...... ental pneumococcal bacteremia.
@nl
type
label
A quantitative analysis of the ...... mental pneumococcal bacteremia
@en
A quantitative analysis of the ...... ental pneumococcal bacteremia.
@nl
prefLabel
A quantitative analysis of the ...... mental pneumococcal bacteremia
@en
A quantitative analysis of the ...... ental pneumococcal bacteremia.
@nl
P2093
P2860
P356
P1476
A quantitative analysis of the ...... mental pneumococcal bacteremia
@en
P2093
P2860
P356
10.1172/JCI110444
P407
P577
1982-01-01T00:00:00Z